Literature DB >> 36082265

Regarding the new ESO guideline on pharmacological interventions for long-term secondary prevention after ischemic stroke or transient ischemic attack: Current evidence does not allow simplified recommendations.

Christian H Nolte1,2,3, Jan F Scheitz1,2, Hebun Erdur1, Heinrich J Audebert1,2.   

Abstract

Entities:  

Year:  2022        PMID： 36082265      PMCID： PMC9446321          DOI： 10.1177/23969873221108745

Source DB:  PubMed          Journal:  Eur Stroke J        ISSN： 2396-9873


× No keyword cloud information.
  4 in total

1.  High-dose atorvastatin after stroke or transient ischemic attack.

Authors:  Pierre Amarenco; Julien Bogousslavsky; Alfred Callahan; Larry B Goldstein; Michael Hennerici; Amy E Rudolph; Henrik Sillesen; Lisa Simunovic; Michael Szarek; K M A Welch; Justin A Zivin
Journal:  N Engl J Med       Date:  2006-08-10       Impact factor: 91.245

2.  A Comparison of Two LDL Cholesterol Targets after Ischemic Stroke.

Authors:  Pierre Amarenco; Jong S Kim; Julien Labreuche; Hugo Charles; Jérémie Abtan; Yannick Béjot; Lucie Cabrejo; Jae-Kwan Cha; Grégory Ducrocq; Maurice Giroud; Celine Guidoux; Cristina Hobeanu; Yong-Jae Kim; Bertrand Lapergue; Philippa C Lavallée; Byung-Chul Lee; Kyung-Bok Lee; Didier Leys; Marie-Hélène Mahagne; Elena Meseguer; Norbert Nighoghossian; Fernando Pico; Yves Samson; Igor Sibon; P Gabriel Steg; Sang-Min Sung; Pierre-Jean Touboul; Emmanuel Touzé; Olivier Varenne; Éric Vicaut; Nessima Yelles; Eric Bruckert
Journal:  N Engl J Med       Date:  2019-11-18       Impact factor: 91.245

3.  Association Between Intensity of Low-Density Lipoprotein Cholesterol Reduction With Statin-Based Therapies and Secondary Stroke Prevention: A Meta-analysis of Randomized Clinical Trials.

Authors:  Meng Lee; Chun-Yu Cheng; Yi-Ling Wu; Jiann-Der Lee; Chia-Yu Hsu; Bruce Ovbiagele
Journal:  JAMA Neurol       Date:  2022-04-01       Impact factor: 18.302

4.  The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study.

Authors:  Naohisa Hosomi; Yoji Nagai; Tatsuo Kohriyama; Toshiho Ohtsuki; Shiro Aoki; Tomohisa Nezu; Hirofumi Maruyama; Norio Sunami; Chiaki Yokota; Kazuo Kitagawa; Yasuo Terayama; Makoto Takagi; Setsuro Ibayashi; Masakazu Nakamura; Hideki Origasa; Masanori Fukushima; Etsuro Mori; Kazuo Minematsu; Shinichiro Uchiyama; Yukito Shinohara; Takenori Yamaguchi; Masayasu Matsumoto
Journal:  EBioMedicine       Date:  2015-08-06       Impact factor: 8.143
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.